|16th October 2019||William S Rosenstadt||115,761||Grant/award etc.||$0.00|
|9th October 2019||Rick Panicucci||500||Grant/award etc.||$0.00|
|28th August 2019||Rick Panicucci||2,000||Grant/award etc.||$0.00|
|31st May 2019||Rick Panicucci||500||Grant/award etc.||$0.00|
|9th April 2019||Rick Panicucci||1,500||Grant/award etc.||$0.00|
|4th January 2019||Rick Panicucci||1,000||Grant/award etc.||$0.00|
|16th November 2018||Rick Panicucci||2,500||Grant/award etc.||$0.00|
|12th July 2018||Denis Corin||6,400||Open or private sale||$2.11||$13,529.60|
|12th July 2018||Rick Panicucci||1,500||Grant/award etc.||$0.00|
|2nd April 2018||Rick Panicucci||1,500||Grant/award etc.||$0.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
Q BioMed, Inc. focuses on acquiring, licensing, and providing resources to life sciences and healthcare companies. The company was founded by Enrique Navas on November 22, 2013 and is headquartered in New York, NY.